Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
UNIVERZA V LJUBLJANI currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed between distinct examiners and 2 distinct art units, showing a split in the university's current prosecution efforts. KUBELIK, ANNE R is identified as the busiest examiner, currently handling 1 pending office action.
The involvement of the art units suggests that the 2 pending office actions cover different technical aspects within the Biotechnology & Pharmaceuticals sector. Because there are multiple examiners, the university must adapt its legal strategy to different sets of examiner feedback. The busiest examiner, KUBELIK, ANNE R, manages 1 of these pending matters, indicating an even distribution of the workload.
Practitioners should monitor the pending office actions to ensure that the arguments presented to the examiners remain consistent. The presence of the distinct art units may lead to different examination timelines or procedural requirements. This dual-track prosecution requires careful coordination to protect the university's interests across the Biotechnology & Pharmaceuticals field.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUBELIK, ANNE R | 1 | 75.8% | -0.7% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.3% | +38.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18266695 | NEW N-PHENYLPYRROLAMIDE INHIBITORS OF DNA GYRASE AND TOPOISOMERASE IV WITH ANTIBACTERIAL ACTIVITY | ABDALHAMEED, MANAHIL MIRGHANI ALI | 2d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18266695 | NEW N-PHENYLPYRROLAMIDE INHIBITORS OF DNA GYRASE AND TOPOISOMERASE IV WITH ANTIBACTERIAL ACTIVITY | ABDALHAMEED, MANAHIL MIRGHANI ALI | 2d overdue |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18644512 | NEW BIO-PESTICIDES FOR CONTROLLING PLANT PESTS | KUBELIK, ANNE R | 1663 | §103DP | Final Rejection | 20d | Pending | Apr 24, 2024 |
| 18266695 | NEW N-PHENYLPYRROLAMIDE INHIBITORS OF DNA GYRASE AND TOPOISOMERASE IV WITH ANTIBACTERIAL ACTIVITY | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103§112 | Non-Final OA | 2d overdue | Pending | Jun 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial